Global Chronic Fatigue Syndrome Drug Market Report By Type (Immune Enhancer & Antivirals (Rintatolimod, Oxymatrine, Valganciclovir, Others), Sleep Enhancing (Gabapentin, Melatonin, Others), Central Nervous System (CNS) Stimulants (Methylphenidate, Lisdexamfetamine Dimesylate, Others), Others), By End User (Hospitals, Clinics, Research Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11215293
June 2021
Report Formats:
The global demand for Chronic Fatigue Syndrome Drug Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2021 - 2027. Regarding volume, the market was calculated XX Kilo Tons in 2020 and forecast to touch XX Kilo Tons by 2027 with a CAGR of XX% during 2021-2027.

Chronic fatigue syndrome (CFS), systemic exertion intolerance disease (SEID), or myalgic encephalomyelitis (ME) is a disorder featured by extreme fatigue or tiredness that doesn’t go away with rest and can’t be explained by an underlying medical condition. It is most common during the 40s and 50s, and women are at three to four times higher risk. Treatment for chronic fatigue syndrome is dependent on symptoms. Each individual has different signs and thus may require different treatment types. Chronic fatigue syndrome drug is usually treated with a combination of medicines, including immune enhancer & antivirals, sleep-enhancing, central nervous system (CNS) stimulants. 

Market Dynamics 

The global chronic fatigue syndrome drug market will continue growing at a healthy rate. The increasing population of people over 50 years presents a significant market opportunity. Moreover, weakening immunity power and growing working population adds to increased chronic fatigue syndrome prevalence. As per United Nations estimates, in 2016, there were 703 million persons aged 65 years or over globally. The number of senior persons is projected to double to 1.5 billion by 2050. Growing FDA approvals, easy accessibility to drugs, low cost of treatment, new product launches, and research on developing a new drug for the syndrome are anticipated to present many lucrative opportunities for the market. However, low awareness about the proper treatment of syndrome and reliance on other kinds of treatment like homeopathy, yoga, and acupuncture restrains the market growth.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chronic fatigue syndrome drug. The growth and trends of Chronic Fatigue Syndrome Drug Industry provide a holistic approach to this study. 

Market Segmentation

This section of the chronic fatigue syndrome drug market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type 
  • Immune Enhancer & Antivirals (Rintatolimod, Oxymatrine, Valganciclovir, Others) 
  • Sleep Enhancing (Gabapentin, Melatonin, Others) 
  • Central Nervous System (CNS) Stimulants (Methylphenidate, Lisdexamfetamine Dimesylate, Others) 
  • Others 

By End User 
  • Hospitals 
  • Clinics 
  • Research Institutes

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Chronic Fatigue Syndrome Drug market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Chronic Fatigue Syndrome Drug Market Share by Region (Representative Graph)

Global Chronic Fatigue Syndrome Drug Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the chronic fatigue syndrome drug market include Hemispherx Biopharma, GP Pharm, USV, Cadila Pharmaceuticals, Goodfellow Pharma, and Torrent Labs. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts. 

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CHRONIC FATIGUE SYNDROME DRUG – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By End User
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CHRONIC FATIGUE SYNDROME DRUG MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Immune Enhancer & Antivirals Market by Regions
       6.6 Sleep Enhancing Market by Regions
       6.5 Central Nervous System Market by Regions
       6.7 Others  Market by Regions
 
7 . GLOBAL CHRONIC FATIGUE SYNDROME DRUG MARKET ANALYSIS BY END USER
       7.1 Overview by End User
       7.2 Historical and Forecast Data
       7.3 Analysis by End User
       7.4 Hospitals  Market by Regions
       7.5 Clinics  Market by Regions
       7.6 Research Institutes Market by Regions
 
8 . GLOBAL CHRONIC FATIGUE SYNDROME DRUG MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE CHRONIC FATIGUE SYNDROME DRUG COMPANIES
       9.1. Chronic Fatigue Syndrome Drug Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CHRONIC FATIGUE SYNDROME DRUG INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Hemispherx Biopharma
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. GP Pharm
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. USV
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Cadila Pharmaceuticals
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Goodfellow Pharma
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Torrent Labs
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type  (Kilo Tons and USD MN)
  • Immune Enhancer & Antivirals Market by Geography (Kilo Tons and USD MN)
  • Sleep Enhancing Market by Geography (Kilo Tons and USD MN)
  • Central Nervous System Market by Geography (Kilo Tons and USD MN)
  • Others  Market by Geography (Kilo Tons and USD MN)
  • Analysis Market by End User  (Kilo Tons and USD MN)
  • Hospitals  Market by Geography (Kilo Tons and USD MN)
  • Clinics  Market by Geography (Kilo Tons and USD MN)
  • Research Institutes Market by Geography (Kilo Tons and USD MN)
  • Global Chronic Fatigue Syndrome Drug Market by Geography (Kilo Tons and USD MN)
  • North America Market Analysis (Kilo Tons and USD MN)
  • United State Market Analysis (Kilo Tons and USD MN)
  • Canada Market Analysis (Kilo Tons and USD MN)
  • Mexico Market Analysis (Kilo Tons and USD MN)
  • Europe Market Analysis (Kilo Tons and USD MN)
  • Europe Market Estimate by Country (Kilo Tons and USD MN)
  • United Kingdom Market Analysis (Kilo Tons and USD MN)
  • France Market Analysis (Kilo Tons and USD MN)
  • Germany Market Analysis (Kilo Tons and USD MN)
  • Italy Market Analysis (Kilo Tons and USD MN)
  • Russia Market Analysis (Kilo Tons and USD MN)
  • Spain Market Analysis (Kilo Tons and USD MN)
  • Rest of Europe Market Analysis (Kilo Tons and USD MN)
  • Asia Pacific Market Analysis (Kilo Tons and USD MN)
  • China Market Analysis (Kilo Tons and USD MN)
  • Japan Market Analysis (Kilo Tons and USD MN)
  • India Market Analysis (Kilo Tons and USD MN)
  • South Korea Market Analysis (Kilo Tons and USD MN)
  • Australia Market Analysis (Kilo Tons and USD MN)
  • Rest of Asia Pacific Market Analysis (Kilo Tons and USD MN)
  • Latin America Market Analysis (Kilo Tons and USD MN)
  • Brazil Market Analysis (Kilo Tons and USD MN)
  • Argentina Market Analysis (Kilo Tons and USD MN)
  • Peru Market Analysis (Kilo Tons and USD MN)
  • Chile Market Analysis (Kilo Tons and USD MN)
  • Rest of Latin America Market Analysis (Kilo Tons and USD MN)
  • Middle East & Africa Market Analysis (Kilo Tons and USD MN)
  • Saudi Arabia Market Analysis (Kilo Tons and USD MN)
  • UAE Market Analysis (Kilo Tons and USD MN)
  • Israel Market Analysis (Kilo Tons and USD MN)
  • South Africa Market Analysis (Kilo Tons and USD MN)
  • Rest of Middle East and Africa Market Analysis (Kilo Tons and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Chronic Fatigue Syndrome Drug Report
  • Market Research Process
  • Market Research Methodology
  • Global Chronic Fatigue Syndrome Drug Market Size, by Region (Kilo Tons and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type  (Kilo Tons and USD MN)
  • Immune Enhancer & Antivirals Market by Geography (Kilo Tons and USD MN)
  • Sleep Enhancing Market by Geography (Kilo Tons and USD MN)
  • Central Nervous System Market by Geography (Kilo Tons and USD MN)
  • Others  Market by Geography (Kilo Tons and USD MN)
  • Global Market Analysis by End User  (Kilo Tons and USD MN)
  • Hospitals  Market by Geography (Kilo Tons and USD MN)
  • Clinics  Market by Geography (Kilo Tons and USD MN)
  • Research Institutes Market by Geography (Kilo Tons and USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials